The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases

Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (S...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric rheumatology online journal Vol. 20; no. 1; p. 106
Main Authors: Legger, G E, Dermer, C W E, Brunger, A F, van Daele, P L A, Nienhuis, H L A
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 24-11-2022
BioMed Central
BMC
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. The aim of this research is to evaluate the possible relation between CRP and SAA. A retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. CRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log SAA. There was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids.
AbstractList Abstract Background Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. Objective The aim of this research is to evaluate the possible relation between CRP and SAA. Methods A retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. Results CRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log10 SAA. Conclusion There was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids.
Background Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. Objective The aim of this research is to evaluate the possible relation between CRP and SAA. Methods A retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. Results CRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log.sub.10SAA. Conclusion There was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids. Keywords: Amyloidosis, Familial Mediterranean fever, Hereditary autoinflammatory diseases, Inflammation, Acute-phase proteins, C-reactive protein, Serum amyloid A protein
BACKGROUNDAutoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. OBJECTIVEThe aim of this research is to evaluate the possible relation between CRP and SAA. METHODSA retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. RESULTSCRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log10SAA. CONCLUSIONThere was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids.
Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. The aim of this research is to evaluate the possible relation between CRP and SAA. A retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. CRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log.sub.10SAA. There was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids.
Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidosis is caused by extracellular deposition of soluble serum amyloid A (SAA) proteins as insoluble amyloid fibrils leading to organ damage. Prolonged high levels of SAA are a prerequisite to develop AA amyloidosis. Since measurement of SAA is relatively expensive and sometimes unavailable, C-reactive protein (CRP) is often used as a surrogacy marker to test for inflammation. The aim of this research is to evaluate the possible relation between CRP and SAA. A retrospective cohort of patients with autoinflammatory diseases (n = 99) where SAA and CRP blood testing was performed in the period between 2015 and 2021 in the University Medical Centre in Groningen was used to investigate the correlation between CRP and SAA. CRP and SAA have a high correlation (rho = 0.755, p < 0.001). A CRP value below 0.45 mg/L results in 100% sensitivity for SAA below 4 mg/L. CRP below 5 mg/L is a good predictor of SAA below 4 mg/L with 85.4% sensitivity and 83.6% specificity. Only prednisone and erythrocyte sedimentation rate (ESR) significantly influence the relation between CRP and log SAA. There was a significant correlation between CRP and SAA in our retrospective cohort. CRP levels below 5 mg/L proved to be highly predictive of SAA levels below 4 mg/L. This may not be true for patients on steroids.
ArticleNumber 106
Audience Academic
Author Nienhuis, H L A
Dermer, C W E
Legger, G E
van Daele, P L A
Brunger, A F
Author_xml – sequence: 1
  givenname: G E
  orcidid: 0000-0002-9576-0904
  surname: Legger
  fullname: Legger, G E
  email: g.e.legger@umcg.nl
  organization: Department of Pediatric Rheumatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. g.e.legger@umcg.nl
– sequence: 2
  givenname: C W E
  surname: Dermer
  fullname: Dermer, C W E
  organization: Department of Pediatric Rheumatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
– sequence: 3
  givenname: A F
  surname: Brunger
  fullname: Brunger, A F
  organization: Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
– sequence: 4
  givenname: P L A
  surname: van Daele
  fullname: van Daele, P L A
  organization: Department of Internal medicine, section allergy and clinical Immunology, Erasmus University, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 5
  givenname: H L A
  surname: Nienhuis
  fullname: Nienhuis, H L A
  organization: Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36434581$$D View this record in MEDLINE/PubMed
BookMark eNptkk1rGzEQhpeS0ny0f6CHIiiUXjaVVh-7uhSM6Ucg0Et6FrPSrK2wu3IlOcH_vnKcBhuKDpJGz7zMjN7L6mwOM1bVe0avGevUl8QarXRNm6amtJVtrV9VF0wKVa5anR2dz6vLlO4plbJwb6pzrgQXsmMX1XC3RhJxhOzDTHrMj4gzWdYRwWb_gGQTQ0Y_E5gdSRi3E4FpNwbvyIKU8KYk4pwTefR5TWCbg5-HEaYJcog74nxCSJjeVq8HGBO-e96vqt_fv90tf9a3v37cLBe3tZVa5Jo5JwcFwjUalG5bKnpkwtrBCjk0qu1QAbcdk73ig5Cyt7pBDr1Ap10HA7-qbg66LsC92UQ_QdyZAN48BUJcGYjZ2xGN7CjlXS96OfRCOdUJ1ghajpxpkJoXra8Hrc22n9DZ0maE8UT09GX2a7MKD0a3ZeasLQKfnwVi-LPFlM3kk8VxhBnDNpmmFVRS3Xa6oB8P6ApKaWWEoSjaPW4WLeeKa6abQl3_hyrL4eRtMcfgS_wk4dNRwhphzOsUxu3-s9Mp2BxAG0NKEYeXNhk1e7OZg9lMMZt5MpvZF_3heEAvKf_cxf8C5C3RJA
CitedBy_id crossref_primary_10_1016_j_ejim_2024_04_024
crossref_primary_10_1053_j_ajkd_2023_07_020
crossref_primary_10_1007_s11356_023_27916_z
crossref_primary_10_1016_j_gene_2024_148222
crossref_primary_10_3389_fneur_2023_1219604
Cites_doi 10.1002/art.37827
10.1056/NEJMoa070265
10.1007/s00403-019-02014-8
10.1007/s00393-020-00778-3
10.1136/annrheumdis-2013-204991
10.1080/13506129.2018.1549825
10.1080/00365510310001636
10.1007/s00296-006-0265-6
10.1136/annrheumdis-2013-203666
10.1080/21551197.2018.1564200
10.3109/1354750X.2011.607189
10.3109/00365519709084584
10.1136/vr.154.26.814
10.1042/cs0680233
10.1182/blood-2009-07-230722
10.1186/s10020-018-0047-0
10.1007/s10067-020-05249-3
10.1093/rheumatology/kei279
10.1084/jem.140.4.1102
10.1016/j.clinbiochem.2016.11.008
10.1159/000497375
10.1016/j.semarthrit.2007.03.005
10.1002/14651858.CD010893.pub3
10.1038/nri.2017.1
10.1016/j.proghi.2012.03.001
10.1097/RHU.0000000000001134
10.1056/NEJM199902113400607
10.1080/13506129.2019.1693359
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: The Author(s) 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1186/s12969-022-00757-9
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ : Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1546-0096
EndPage 106
ExternalDocumentID oai_doaj_org_article_580038b4b5fb46d6841240b46319a593
A733639192
10_1186_s12969_022_00757_9
36434581
Genre Journal Article
GroupedDBID ---
-A0
0R~
123
29O
2WC
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
AFGXO
7X8
5PM
ID FETCH-LOGICAL-c594t-1dd5f6a4d29a697704be14ccfc45f2678e6a3c815b63f455bc92e3ab4ed9d8af3
IEDL.DBID RPM
ISSN 1546-0096
IngestDate Tue Oct 22 14:59:50 EDT 2024
Tue Sep 17 21:31:52 EDT 2024
Sat Oct 05 04:20:54 EDT 2024
Tue Nov 19 21:01:12 EST 2024
Tue Nov 12 23:26:38 EST 2024
Tue Aug 20 22:14:08 EDT 2024
Thu Nov 21 21:52:24 EST 2024
Sat Sep 28 08:21:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords C-reactive protein
Acute-phase proteins
Hereditary autoinflammatory diseases
Amyloidosis
Familial Mediterranean fever
Inflammation
Serum amyloid A protein
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-1dd5f6a4d29a697704be14ccfc45f2678e6a3c815b63f455bc92e3ab4ed9d8af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9576-0904
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700917/
PMID 36434581
PQID 2740509789
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_580038b4b5fb46d6841240b46319a593
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9700917
proquest_miscellaneous_2740509789
gale_infotracmisc_A733639192
gale_infotracacademiconefile_A733639192
gale_healthsolutions_A733639192
crossref_primary_10_1186_s12969_022_00757_9
pubmed_primary_36434581
PublicationCentury 2000
PublicationDate 2022-11-24
PublicationDateYYYYMMDD 2022-11-24
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-24
  day: 24
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Pediatric rheumatology online journal
PublicationTitleAlternate Pediatr Rheumatol Online J
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Gabay (757_CR1) 1999; 340
S Martínez-Subiela (757_CR30) 2004; 154
757_CR18
757_CR16
757_CR14
T Fülöp (757_CR26) 2019; 65
S Can Sandikci (757_CR24) 2021; 40
M Tunca (757_CR10) 2005; 84
HJ Lachmann (757_CR4) 2007; 356
S Hallan (757_CR19) 1997; 57
KN Porter Starr (757_CR27) 2019; 38
M Piram (757_CR23) 2014; 73
F Yalçânkaya (757_CR8) 2007; 27
AF Brunger (757_CR2) 2020; 27
F Yalçinkaya (757_CR17) 2007; 27
757_CR9
CPJ Maury (757_CR15) 1985; 68
R Levy (757_CR11) 2015; 74
M Çakan (757_CR6) 2021; 27
HJ Lachmann (757_CR5) 2006; 45
S Takata (757_CR31) 2011; 16
MD Benson (757_CR20) 2018; 25
T Lane (757_CR12) 2013; 65
RP Linke (757_CR22) 2012; 47
JA Vrana (757_CR21) 2009; 114
DW Cain (757_CR29) 2017; 17
KS Stojanovic (757_CR7) 2017; 50
Y Berkun (757_CR13) 2007; 37
GH Sack (757_CR3) 2018; 24
N Akdogan (757_CR25) 2019; 312
T Shirahama (757_CR28) 1974; 140
References_xml – volume: 65
  start-page: 1116
  issue: 4
  year: 2013
  ident: 757_CR12
  publication-title: Arthritis Rheum
  doi: 10.1002/art.37827
  contributor:
    fullname: T Lane
– volume: 356
  start-page: 2361
  issue: 23
  year: 2007
  ident: 757_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa070265
  contributor:
    fullname: HJ Lachmann
– volume: 312
  start-page: 255
  issue: 4
  year: 2019
  ident: 757_CR25
  publication-title: Arch DermatolRes
  doi: 10.1007/s00403-019-02014-8
  contributor:
    fullname: N Akdogan
– ident: 757_CR9
  doi: 10.1007/s00393-020-00778-3
– volume: 74
  start-page: 2043
  issue: 11
  year: 2015
  ident: 757_CR11
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204991
  contributor:
    fullname: R Levy
– volume: 25
  start-page: 215
  issue: 4
  year: 2018
  ident: 757_CR20
  publication-title: Amyloid
  doi: 10.1080/13506129.2018.1549825
  contributor:
    fullname: MD Benson
– ident: 757_CR18
– ident: 757_CR14
  doi: 10.1080/00365510310001636
– volume: 27
  start-page: 517
  issue: 6
  year: 2007
  ident: 757_CR17
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-006-0265-6
  contributor:
    fullname: F Yalçinkaya
– volume: 73
  start-page: 2168
  issue: 12
  year: 2014
  ident: 757_CR23
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203666
  contributor:
    fullname: M Piram
– volume: 38
  start-page: 33
  issue: 1
  year: 2019
  ident: 757_CR27
  publication-title: J Nutr Gerontol Geriatr
  doi: 10.1080/21551197.2018.1564200
  contributor:
    fullname: KN Porter Starr
– volume: 16
  start-page: 530
  issue: 6
  year: 2011
  ident: 757_CR31
  publication-title: Biomarkers
  doi: 10.3109/1354750X.2011.607189
  contributor:
    fullname: S Takata
– volume: 27
  start-page: 517
  year: 2007
  ident: 757_CR8
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-006-0265-6
  contributor:
    fullname: F Yalçânkaya
– volume: 57
  start-page: 373
  issue: 5
  year: 1997
  ident: 757_CR19
  publication-title: Scand J Clin Lab Invest
  doi: 10.3109/00365519709084584
  contributor:
    fullname: S Hallan
– volume: 154
  start-page: 814
  issue: 26
  year: 2004
  ident: 757_CR30
  publication-title: Vet Record
  doi: 10.1136/vr.154.26.814
  contributor:
    fullname: S Martínez-Subiela
– volume: 68
  start-page: 233
  issue: 2
  year: 1985
  ident: 757_CR15
  publication-title: Clin Sci
  doi: 10.1042/cs0680233
  contributor:
    fullname: CPJ Maury
– volume: 114
  start-page: 4957
  issue: 24
  year: 2009
  ident: 757_CR21
  publication-title: Blood
  doi: 10.1182/blood-2009-07-230722
  contributor:
    fullname: JA Vrana
– volume: 24
  start-page: 1
  issue: 1
  year: 2018
  ident: 757_CR3
  publication-title: Mol Med
  doi: 10.1186/s10020-018-0047-0
  contributor:
    fullname: GH Sack
– volume: 40
  start-page: 669
  issue: 2
  year: 2021
  ident: 757_CR24
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-020-05249-3
  contributor:
    fullname: S Can Sandikci
– volume: 45
  start-page: 746
  issue: 6
  year: 2006
  ident: 757_CR5
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kei279
  contributor:
    fullname: HJ Lachmann
– volume: 140
  start-page: 1102
  issue: 4
  year: 1974
  ident: 757_CR28
  publication-title: J Exp Med
  doi: 10.1084/jem.140.4.1102
  contributor:
    fullname: T Shirahama
– volume: 50
  start-page: 206
  issue: 4–5
  year: 2017
  ident: 757_CR7
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2016.11.008
  contributor:
    fullname: KS Stojanovic
– volume: 65
  start-page: 495
  issue: 5
  year: 2019
  ident: 757_CR26
  publication-title: Gerontology
  doi: 10.1159/000497375
  contributor:
    fullname: T Fülöp
– volume: 37
  start-page: 182
  issue: 3
  year: 2007
  ident: 757_CR13
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2007.03.005
  contributor:
    fullname: Y Berkun
– ident: 757_CR16
  doi: 10.1002/14651858.CD010893.pub3
– volume: 17
  start-page: 233
  issue: 4
  year: 2017
  ident: 757_CR29
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2017.1
  contributor:
    fullname: DW Cain
– volume: 47
  start-page: 61
  issue: 2
  year: 2012
  ident: 757_CR22
  publication-title: Prog Histochem Cytochem
  doi: 10.1016/j.proghi.2012.03.001
  contributor:
    fullname: RP Linke
– volume: 27
  start-page: 1
  issue: 1
  year: 2021
  ident: 757_CR6
  publication-title: J Clin Rheumatol
  doi: 10.1097/RHU.0000000000001134
  contributor:
    fullname: M Çakan
– volume: 340
  start-page: 448
  issue: 6
  year: 1999
  ident: 757_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199902113400607
  contributor:
    fullname: C Gabay
– volume: 27
  start-page: 1
  issue: 1
  year: 2020
  ident: 757_CR2
  publication-title: Amyloid
  doi: 10.1080/13506129.2019.1693359
  contributor:
    fullname: AF Brunger
– volume: 84
  start-page: 1
  issue: 1
  year: 2005
  ident: 757_CR10
  publication-title: Med Int
  contributor:
    fullname: M Tunca
SSID ssj0055075
Score 2.3410313
Snippet Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of...
Background Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared...
BACKGROUNDAutoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared...
Abstract Background Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 106
SubjectTerms Acute-phase proteins
Amyloidosis
Blood
C-reactive protein
C-Reactive Protein - metabolism
Care and treatment
Familial Mediterranean fever
Hereditary autoinflammatory diseases
Hereditary Autoinflammatory Diseases - diagnosis
Humans
Inflammation
Medical examination
Proteins
Retrospective Studies
Serum Amyloid A Protein - analysis
Serum Amyloid A Protein - metabolism
SummonAdditionalLinks – databaseName: DOAJ : Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QF0fIKLa2RkDggq3H8Pi6lVS_lAkjcLD_FHjaLms3_Z-xkV404cOEWxXOI_X32jDPjzwh9AB-hZOszkUYxwkXgxEftSPa-ldpImqpc0-039fWn_nJdZHIOV32VmrBJHngauEuhS_LKcy-y5zJKXa5LbuERuOOEmXQ-W7XfTE1rcBHpEvsjMlpeDuDVpCGlcr34SEXMwg1Vtf6_1-QHTmlZMPnAA908R8_m0BGvpk8-Ro9Sf4Ke3M3J8RcoA-T4fi5uw3MBFr4iEBbWRQ1XTYZ1j10fMTBv3GC3gf36OuIVhtezxOqAy79Z7MbdFtgHhNnURDyeUznDS_Tj5vr71S2Zr1EgQRi-IzRGkaXjsTMOEFEt94nyEHLgInfgrJJ0LGgqvGSZC-GD6RJznqdoALbMXqGjftunNwhzHVikMXHaZh5y53QMAEKkjPOcXGrQp_2o2t-TWoatuwwt7YSBBQxsxcCaBn0uA3-wLErX9QXgb2f87b_wb9BFgc1Ox0YP89Wuis4jMxDANuhjtSgzFtALbj54AF0q2lcLy7OFJcy0sGh-v6eGLU2lPK1P23GwsLUvOjpKQ59eT1Q59IpBzMeFpg1SCxItur1s6de_qtC3URABU_X2f4zTKXraFf5TSjp-ho5292N6hx4PcTyvU-cPUZIbxw
  priority: 102
  providerName: Directory of Open Access Journals
Title The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases
URI https://www.ncbi.nlm.nih.gov/pubmed/36434581
https://search.proquest.com/docview/2740509789
https://pubmed.ncbi.nlm.nih.gov/PMC9700917
https://doaj.org/article/580038b4b5fb46d6841240b46319a593
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtwgFEWdLKpuqr47TZpSqVIXFRljA4blZJoom1RVH1LVDeKZjtTxROPx_-eC7VGs7rqxLINlwzlwL3A5IPQBbEQtChuJUHVFGHeMWC8NidYWQipBQ5Zruvpef_klP18kmRw-7oXJQfvOrs-av5uzZv0nx1bebtxijBNbfL1eqRo8A1ovZmgGvuE4RO-736TPxcfdMVIsWjBoQpEUtJ7MY03UxAJlof5_u-N79mgaK3nP-Fw-QY8HrxEv-797ih6E5hl6eD2siz9HEdDGuyGuDQ-xV3hFwCPM_RnOcgzrBpvGYyBdt8FmA0P1tcdLDI8HddUWp2lZbLr9FogHXNnkNXg8rOK0L9DPy4sfqysynKBAHFdsT6j3PArDfKkMgFEXzAbKnIuO8ViCnQrCVE5SbkUVGefWqTJUxrLgFSAWq5foqNk24TXCTLrKUx8YLSJzsTTSO8OVpxVjMZgwR5_GWtW3vVCGzgMMKXSPgQYMdMZAqzk6TxV_yJlErvOD7e5GD1BrLtO6pWWWR8uEFzKdlF3ALXQb8Olqjt4l2HS_Y_TQVPUySTxWCnzXOfqYc6TGCug5M-w5gCIl2atJzpNJTmhkbpL8fqSGTkkpMq0J267VMKpPEjq1hDK96qlyKFUF7h7jks5RPSHRpNjTFKB81vgeKP7mv988Ro_KRHpKSclO0NF-14W3aNb67jTPO8D12_nv09x27gCiIx5k
link.rule.ids 230,315,729,782,786,866,887,2107,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZokaAX3pSFQo2ExAG5Gye2Yx-XpdUiuhUSReJm-QkrsdlqH_-fsZOsGnHrLbIdJc73jWccjz8j9AF8RC0KG4lQdUUYd4xYLw2J1hZCKkFDlmua_aivfskv50kmh_d7YXLSvrOLs-bv8qxZ_Mm5lTdLN-7zxMbf51NVQ2RA6_EBug_2WpT9JL0dgJNCF-_3x0gx3oBLE4qktPXkIGuiBj4oS_X_PyDf8kjDbMlb7ufi8R1f_Al61MWbeNJWP0X3QvMMPZh3K-rPUQSe4HWXEYe7rC08JRBL5pEQZyGHRYNN4zHQdbfEZgmT_IXHEwzFnS7rBqcfutjstiugLLBsmVfvcbf-s3mBfl6cX09npDt7gTiu2JZQ73kUhvlSGYCxLpgNlDkXHeOxBA8XhKmcpNyKKjLOrVNlqIxlwSvAOlYv0WGzasIrhJl0lac-MFpE5mJppHeGK08rxmIwYYQ-9Wjom1ZiQ-epiRS6xU4Ddjpjp9UIfU6A7VsmeexcsFr_1t231lymFU_LLI-WCS9kOmO7gEsYcODR1QidJrh1u9d0b-R6ksQhKwVR7wh9zC2SmQPqznS7FaBLSTBr0PJk0BLM0w2q3_eU0qkq5bQ1YbXb6LJmSXynltCn45Zi-15VECgyLukI1QPyDbo9rAHOZXXwjmOv73znKXo4u55f6suvV9_eoKMyGQ6lpGQn6HC73oW36GDjd--yzf0DMi8x6w
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELZokSou5U0DhRoJiQNyd71re-1jSBsVQatKgMTN8hMikU2Ux_9n7N1EXXGD28qeKOt833jG8fgzQu8gRjSitJEI1dSEcceI9dKQaG0ppBI0ZLmmq6_NzQ95cZlkcvZXfeWifWdn5-3v-Xk7-5VrK5dzV-zqxIrb64lqIDOgTbH0sThA98FnS7ZbqHeTcFLp4rszMlIUawhrQpFUup6CZEPUIA5luf6_J-U7UWlYMXknBE0f_sfLP0LHfd6Jx53JY3QvtE_Q0XW_s_4UReALXvWVcbiv3sITAjllnhFxFnSYtdi0HgNtt3Ns5rDYn3k8xtDc67OucfpjF5vtZgHUBbbN8y4-7veB1s_Q9-nlt8kV6e9gII4rtiHUex6FYb5SBuBsSmYDZc5Fx3isINIFYWonKbeijoxz61QVamNZ8Aowj_VzdNgu2nCCMJOu9tQHRsvIXKyM9M5w5WnNWAwmjNCHHSJ62Ult6LxEkUJ3-GnAT2f8tBqhjwm0vWWSyc4Ni9VP3f_emsu082mZ5dEy4YVMd22X8AgTD3x1PUJnCXLdnTndO7seJ5HIWkH2O0Lvs0Vyd0Demf7UAgwpCWcNLE8HluCmbtD9dkcrnbpSbVsbFtu1rhqWRHgaCWN60dFsP6oaEkbGJR2hZkDAwbCHPcC7rBLe8-zlP3_yDB3dXkz1l083n1-hB1XyHUpJxU7R4Wa1Da_Rwdpv32S3-wO4eDRr
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relation+between+C-reactive+protein+and+serum+amyloid+A+in+patients+with+autoinflammatory+diseases&rft.jtitle=Pediatric+rheumatology+online+journal&rft.au=Legger%2C+G+E&rft.au=Dermer%2C+C+W+E&rft.au=Brunger%2C+A+F&rft.au=van+Daele%2C+P+L+A&rft.date=2022-11-24&rft.eissn=1546-0096&rft.volume=20&rft.issue=1&rft.spage=106&rft.epage=106&rft_id=info:doi/10.1186%2Fs12969-022-00757-9&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1546-0096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1546-0096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1546-0096&client=summon